STRAP

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, STRAP mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated STRAP data layer compared with 23 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher STRAP mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated STRAP expression acts as an unfavorable survival marker, although some lineages such as LUAD and LSCC show a favorable association.

CCRCC, LUAD, and LSCC are the cancer types where STRAP mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
CCRCCOSTertileAll0.5851.000.00628view →
LUADOSQuartileIII,IV1.0000.289.0402view →
LSCCDFSQuartileAll1.0000.923.0291view →
Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

STRAP–CCRCC (OS)

Kaplan–Meier survival curve for STRAP mass-spec protein-high vs -low samples in CCRCC.

Open the CCRCC breakdown →

Exploration